Skip to main content
An official website of the United States government

Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Asefa, Wosene
 wosene.asefa@nih.gov
240-276-6422 		5E504 Program Support Assistant | Chemopreventive Agent Development
Biswas, Kajal, Ph.D.
 kajal.biswas2@nih.gov
240-276-5614 		5E540 Program Officer | Chemopreventive Agent Development
Cholewa, Brian, Ph.D.
 brian.cholewa@nih.gov
240-276-7545 		5E446 Deputy Chief | Chemopreventive Agent Development
Clifford, John, Ph.D.
 john.clifford@nih.gov
202-235-4482 		5E430 Program Officer | Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D.
 vignesh.gunasekharan@nih.gov
240-276-5814 		5E438 Program Officer | Chemopreventive Agent Development
Mohammed, Altaf, Ph.D.
 altaf.mohammed@nih.gov
240-276-6082 		5E542 Deputy Chief | Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S.
 ancy.nalli@nih.gov
202-276-5265 		5E536 Program Officer | Chemopreventive Agent Development
Sei, Shizuko, M.D.
 shizuko.sei@nih.gov
240-276-5005 		5E452 Co-Chief | Chemopreventive Agent Development
Shoemaker, Robert, Ph.D.
 robert.shoemaker@nih.gov
240-276-7077 		5E454 Co-Chief | Chemopreventive Agent Development
Acting Chief | Nutritional Science
Vlad, Anda, M.D., Ph.D.
 anda.vlad@nih.gov
240-276-6422 		5E538 Program Officer | Chemopreventive Agent Development

Grants

PI Name PI Organization Title Grant Number Program Official
Sanchez, Eduardo Vilar

University Of Tx Md Anderson Can Ctr
United States

 Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome 5R01CA260761-04 Asad Umar, D.V.M., Ph.D.
Sanda, Martin G

Emory University
United States

 Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern 5U01CA113913-18 Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sands, Stephen Alan

Sloan-Kettering Inst Can Research
United States

 Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR) 5R01CA283045-02 Marjorie Perloff, M.D.
Santomasso, Bianca Denise

Sloan-Kettering Inst Can Research
United States

 Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy 5R01CA293922-02 Monica Epstein, B.S.N., RN, OCN
Santos-Reyes, Luis Javier

Comprehensive Cancer Center/ Univ/Pr
United States

 Puerto Rico NCI Community Oncology Research Program (Puerto Rico NCORP) 3UG1CA189862-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Saphner, Thomas J

Aurora Health Care, Inc.
United States

 Aurora NCORP Community Site 3UG1CA190140-11S1 Vanessa A. White, M.P.H.
Schallenkamp, John M.

Montana Cancer Consortium
United States

 Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming 3UG1CA189872-11S1 Vanessa A. White, M.P.H.
Schaverien, Mark V

University Of Tx Md Anderson Can Ctr
United States

 Lymphedema Prevention Through Immediate Lymphatic Reconstruction 5R01CA292908-02 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Schedin, Pepper J

Oregon Health & Science University
United States

 NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention 5R01CA169175-11 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Schenker, Yael

University Of Pittsburgh At Pittsburgh
United States

 Patient-centered and efficacious advance care planning in cancer: the PEACe comparative effectiveness trial 5R01CA235730-06 Brennan Streck, Ph.D., RN, M.P.H.
Schmidt, Christian Maximillian

Indiana University Indianapolis
United States

 Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer 5U01CA239522-05 Claire Zhu, Ph.D.
Schmit, Stephanie L.

Cleveland Clinic Lerner Com-Cwru
United States

 Variation in tumor-associated immune profiles and colorectal cancer outcomes 5R01CA248931-05 Asad Umar, D.V.M., Ph.D.
Schoen, Robert E.

University Of Pittsburgh At Pittsburgh
United States

 Blood-Based Testing for Advanced Adenoma 5U01CA271884-04 Matthew Young, Ph.D.
Schroeck, Florian R

Veterans Education/Res/Assn/North/Ne
United States

 Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance 5R37CA275916-03 Claire Zhu, Ph.D.
Schuetze, Scott Michael

University Of Michigan At Ann Arbor
United States

 Early Phase Clinical Cancer Prevention Consortium 2UG1CA242632-06 Donald Johnsey